Stocks-BPMC-Blueprint Medicines Corp

BPMC Blueprint Medicines Corp

52.07 0.14 (0.27%)
Market OpenDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Blueprint Medicines Corp's revenues increased by 13.30% and amounted to 204.04M. Net income increased by 13.44% to -557.52M. Net assets increased by 9.54% to 1.33B and EPS increased from -11.01 to -9.35.
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
Net Profit Margin
Operating Margin
Return On Investment